Premium
The Relationship between Periodontal Interventions and Healthcare Costs and Utilization. Evidence from an Integrated Dental, Medical, and Pharmacy Commercial Claims Database
Author(s) -
Nasseh Kamyar,
Vujicic Marko,
Glick Michael
Publication year - 2017
Publication title -
health economics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.55
H-Index - 109
eISSN - 1099-1050
pISSN - 1057-9230
DOI - 10.1002/hec.3316
Subject(s) - pharmacy , medicine , health care , glycemic , psychological intervention , medical costs , family medicine , diabetes mellitus , dentistry , nursing , endocrinology , economics , economic growth
Periodontal disease has been linked to poor glycemic control among individuals with type 2 diabetes. Using integrated dental, medical, and pharmacy commercial claims from Truven MarketScan® Research Databases, we implement inverse probability weighting and doubly robust methods to estimate a relationship between a periodontal intervention and healthcare costs and utilization. Among individuals newly diagnosed with type 2 diabetes, we find that a periodontal intervention is associated with lower total healthcare costs (−$1799), lower total medical costs excluding pharmacy costs (−$1577), and lower total type 2 diabetes‐related healthcare costs (−$408). © 2016 The Authors. Health Economics Published by John Wiley & Sons Ltd.